Kinarus Therapeutics Holding AG (XSWX:KNRS) EV-to-EBIT : -35.35 (As of Jun. 20, 2024)

Kinarus Therapeutics Holding AG EV-to-EBIT Chart

Kinarus Therapeutics Holding AG Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EV-to-EBIT		Get a 7-Day Free Trial					-8.76	-1.61	-4.23	7,439.73	-99.35

Kinarus Therapeutics Holding AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
EV-to-EBIT	Get a 7-Day Free Trial															-4.23	-	7,439.73	-	-99.35

Competitive Comparison of Kinarus Therapeutics Holding AG's EV-to-EBIT

For the Airports & Air Services subindustry, Kinarus Therapeutics Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kinarus Therapeutics Holding AG's EV-to-EBIT Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, Kinarus Therapeutics Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kinarus Therapeutics Holding AG's EV-to-EBIT falls into.

Kinarus Therapeutics Holding AG EV-to-EBIT Calculation

Kinarus Therapeutics Holding AG's EV-to-EBIT for today is calculated as:

Kinarus Therapeutics Holding AG's current Enterprise Value is CHF4.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kinarus Therapeutics Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kinarus Therapeutics Holding AG  (XSWX:KNRS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kinarus Therapeutics Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2021 is calculated as:

Kinarus Therapeutics Holding AG's Enterprise Value for the quarter that ended in Dec. 2021 was CHF12.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kinarus Therapeutics Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kinarus Therapeutics Holding AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description